SEC Form 4 · accession 0001225208-16-033429
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry L Wood
Officer — CVP, THV Replacement
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 7:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 12, 2016 | A | 2,850 | $0.00 | A | 90,760 | D | |
| Common StockF3 | holding | — | — | — | 165 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire)F5,F4 | $105.59 | May 12, 2016 | A | 26,100 | A | May 12, 2017 | May 11, 2023 | Common Stock | 26,100 | 26,100 | D |
| Performance RightsF6,F5 | — | May 12, 2016 | A | 3,550 | A | — | — | Common Stock | 3,550 | 3,550 | D |
Explanation of responses
- F1These restricted stock units were granted on May 12, 2016 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date.
- F2On December 11, 2015, the common stock of Edwards Lifesciences Corporation ("Issuer") split 2-for-1, resulting in the reporting persons' ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This amount includes quarterly acquisition of shares under Issuer's Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.
- F3Shares represented on the most recent statement of the 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equity to share equivalents.
- F4These options were granted on May 12, 2016 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- F5This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- F6Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 12, 2016 and scheduled to vest on May 12, 2019. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from zero percent (0%) of the Target Award to one hundred seventy five percent (175%) of the Target Award.